EOSINOPHILIC GRANULOMATOSIS Clinical Trials

6 clinical trials for EOSINOPHILIC GRANULOMATOSIS across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NS-229 IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS — RECRUITING · PHASE2
• 52-WEEK, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP, MULTI-CENTRE, NON-INFERIORITY STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DEPEMOKIMAB COMPARED WITH MEPOLIZUMAB IN ADULTS WITH RELAPSING OR REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) RECEIVING STANDARD OF CARE (SOC) THERAPY — RECRUITING
• A RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED 52-WEEK STUDY WITH AN OPEN-LABEL EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF BENRALIZUMAB COMPARED TO MEPOLIZUMAB IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN PATIENTS RECEIVING STANDARD OF CARE THERAPY — RECRUITING
• A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF MEPOLIZUMAB IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS IN SUBJECTS RECEIVING STANDARD OF CARE THERAPY — RECRUITING
• Impact of Vasculitis on Employment and Income — COMPLETED
• MEPOLIZUMAB LONG-TERM ACCESS PROGRAMME FOR SUBJECTS WHO PARTICIPATED IN STUDY MEA115921 (PLACEBO-CONTROLLED STUDY OF MEPOLIZUMAB IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN SUBJECTS RECEIVING STANDARD-OF-CARE THERAPY) — COMPLETED

Refine this search